American Medical News Examines Clinical Trials Outsourcing
Main Category: Clinical Trials / Drug TrialsAlso Included In: Pharma Industry / Biotech Industry
Article Date: 10 Sep 2009 - 5:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
American Medical News examines the ethical considerations of outsourcing pharmaceutical clinical trials to developing countries. The article highlights how it is less expensive for a drug company to conduct a trial in India, where it runs about $2,000 to track a patient through a trial, compared to the cost in the U.S., which is "10 times more." The disparities between participants in the two countries in terms of income, education and access to care are "stark" and the playing field "uneven," writes American Medical News.
While twenty years ago, most U.S. companies conducted clinical trials on their home soil, now "[t]he 20 largest U.S.-based drugmakers conduct about a third of their phase III clinical trials outside the country, and a majority of their study sites also are elsewhere, says a Feb. 19 article in The New England Journal of Medicine," according to American Medical News.
"There are just going to be more people in other parts of the world who are having health issues that need to be addressed and are ready to consent to clinical trials, because really it is the only mechanism for receiving care," said Jill Fisher of Vanderbilt University's Center for Biomedical Ethics and Society. She added that "clinical trials are a problematic kind of care, because it comes in the context of a study intervention. But people are ready to enroll, because they see it as such an incredible advantage over basically nothing."
The article outlines additional concerns about outsourcing clinical trials, such as limited ethical oversight of trials, language barriers, cultural norms and government corruption, as well as comments by other experts on the pros and cons of clinical-trial outsourcing (O'Reilly, 9/7).
This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.
© Henry J. Kaiser Family Foundation. All rights reserved.
Visit our clinical trials / drug trials section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/163539.php>
APA
http://www.medicalnewstoday.com/releases/163539.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




